Cheng B |
Advances in prevention and treatment of MAC. |
1995 |
PI Perspect |
pmid:11363104
|
Hunter RP et al. |
Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. |
1995 |
J. Vet. Pharmacol. Ther. |
pmid:7752305
|
Ives DV et al. |
Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. |
1995 |
AIDS |
pmid:7755914
|
Onyeji CO et al. |
Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. |
1995 |
J. Infect. Dis. |
pmid:7658075
|
Debets-Ossenkopp YJ et al. |
Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents. |
1995 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:7649202
|
Ramadan MA et al. |
Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. |
1995 |
J. Med. Microbiol. |
pmid:7752216
|
Clancy J et al. |
Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. |
1995 |
J. Antibiot. |
pmid:8557568
|
Amsden GW |
Macrolides versus azalides: a drug interaction update. |
1995 |
Ann Pharmacother |
pmid:8547740
|
Beckers CJ et al. |
Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. |
1995 |
J. Clin. Invest. |
pmid:7814637
|
Friis HM |
[Azithromycin--an exciting new antibiotic]. |
1995 |
Ugeskr. Laeg. |
pmid:7831724
|
Dessau RB |
[Azithromycin]. |
1995 |
Ugeskr. Laeg. |
pmid:7831733
|
Fujii R et al. |
[Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field. Pediatric Study Group of Azithromycin]. |
1995 |
Jpn J Antibiot |
pmid:7474330
|
Sasaki J et al. |
[Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection]. |
1995 |
Jpn J Antibiot |
pmid:7474331
|
Uchino U et al. |
[Effects of azithromycin on fecal flora of healthy adult volunteers]. |
1995 |
Jpn J Antibiot |
pmid:7474332
|
Toscano MA et al. |
[Efficacy and tolerance of azithromycin in respiratory tract infections in children]. |
1995 |
Minerva Pediatr. |
pmid:7476752
|
Scheen AJ |
[Pharma-clinics. Drug of the month. Azithromycin (Zitromax)]. |
1995 |
Rev Med Liege |
pmid:7481274
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486938
|
Worm AM and Osterlind A |
Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis. |
1995 |
Genitourin Med |
pmid:7590717
|
Gastearena I et al. |
Determination of the alpha1-acid glycoprotein binding of azithromycin in vitro by equilibrium dialysis. |
1995 |
J Chemother |
pmid:8904095
|
Domingo S et al. |
Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis. |
1995 |
J Chemother |
pmid:8904096
|